<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Trop Med Hyg</journal-id><journal-id journal-id-type="iso-abbrev">Am. J. Trop. Med. Hyg</journal-id><journal-id journal-id-type="publisher-id">tpmd</journal-id><journal-id journal-id-type="hwp">tropmed</journal-id><journal-title-group><journal-title>The American Journal of Tropical Medicine and Hygiene</journal-title></journal-title-group><issn pub-type="ppub">0002-9637</issn><issn pub-type="epub">1476-1645</issn><publisher><publisher-name>The American Society of Tropical Medicine and Hygiene</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32484155</article-id><article-id pub-id-type="pmc">7410484</article-id><article-id pub-id-type="publisher-id">tpmd200516</article-id><article-id pub-id-type="doi">10.4269/ajtmh.20-0516</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspective Piece</subject></subj-group></article-categories><title-group><article-title>Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gutman</surname><given-names>Julie R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Lucchi</surname><given-names>Naomi W.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cantey</surname><given-names>Paul T.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Steinhardt</surname><given-names>Laura C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Samuels</surname><given-names>Aaron M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kamb</surname><given-names>Mary L.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kapella</surname><given-names>Bryan K.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>McElroy</surname><given-names>Peter D.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Udhayakumar</surname><given-names>Venkatachalam</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lindblade</surname><given-names>Kim A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia;</aff><aff id="aff2"><label>2</label>Parasitic Diseases Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia;</aff><aff id="aff3"><label>3</label>U.S. President&#x02019;s Malaria Initiative, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Address correspondence to Julie R. Gutman, Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, U.S. Centers for Disease Control and Prevention, 1600 Clifton Rd., Mailstop H24-3, Atlanta, GA 30329. E-mail: <email>fff2@cdc.gov</email></corresp><fn fn-type="COI-statement"><p>Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Publication charges for this article were waived due to the ongoing pandemic of COVID-19.</p></fn><fn fn-type="present-address"><p>Authors&#x02019; addresses: Julie R Gutman, Naomi W. Lucchi, Laura C. Steinhardt, Aaron M. Samuels, Peter D. McElroy, Venkatachalam Udhayakumar, and Kim A. Lindblade, Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, E-mails: <email>fff2@cdc.gov</email>, <email>nlucchi@cdc.gov</email>, <email>iyp6@cdc.gov</email>, <email>iyp2@cdc.gov</email>, <email>pgm9@cdc.gov</email>, <email>vxu0@cdc.gov</email>, and <email>kil2@cdc.gov</email>. Paul T. Cantey and Mary L. Kamb, Parasitic Diseases Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, E-mails: <email>gdn9@cdc.gov</email> and <email>mlk5@cdc.gov</email>. Bryan K. Kapella, Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, and U.S. President&#x02019;s Malaria Initiative, Centers for Disease Control and Prevention (CDC), Atlanta, GA, E-mail: <email>bkapella@cdc.gov</email>.</p></fn></author-notes><pub-date pub-type="ppub"><month>8</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>01</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>6</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>103</volume><issue>2</issue><fpage>572</fpage><lpage>577</lpage><history><date date-type="received"><day>19</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>26</day><month>5</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The American Society of Tropical Medicine and Hygiene</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution (CC-BY) License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="tpmd200516.pdf"/><abstract><title>Abstract.</title><p>The COVID-19 pandemic, caused by SARS-CoV-2, have surpassed 5 million cases globally. Current models suggest that low- and middle-income countries (LMICs) will have a similar incidence but substantially lower mortality rate than high-income countries. However, malaria and neglected tropical diseases (NTDs) are prevalent in LMICs, and coinfections are likely. Both malaria and parasitic NTDs can alter immunologic responses to other infectious agents. Malaria can induce a cytokine storm and pro-coagulant state similar to that seen in severe COVID-19. Consequently, coinfections with malaria parasites and SARS-CoV-2 could result in substantially worse outcomes than mono-infections with either pathogen, and could shift the age pattern of severe COVID-19 to younger age-groups. Enhancing surveillance platforms could provide signals that indicate whether malaria, NTDs, and COVID-19 are syndemics (synergistic epidemics). Based on the prevalence of malaria and NTDs in specific localities, efforts to characterize COVID-19 in LMICs could be expanded by adding testing for malaria and NTDs. Such additional testing would allow the determination of the rates of coinfection and comparison of severity of outcomes by infection status, greatly improving the understanding of the epidemiology of COVID-19 in LMICs and potentially helping to mitigate its impact.</p></abstract><counts><page-count count="6"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>The COVID-19 pandemic caused by SARS-CoV-2, a novel coronavirus, has now reached all corners of the world, and cases have surpassed 5 million.<sup><xref rid="b1" ref-type="bibr">1</xref></sup> SARS-CoV-2 is currently spreading in low- and middle-income countries (LMICs) that experience the highest rates of malaria and neglected tropical diseases (NTDs). Neglected tropical diseases refer to a diverse group of communicable diseases caused by parasites, fungi, bacteria, and viruses that occur primarily in tropical and subtropical climates; only parasitic NTDs are considered here (<xref rid="t1" ref-type="table">Table 1</xref>). With many LMICs implementing movement restrictions or ordering their populations to stay at home to limit SARS-CoV-2 transmission, the threat to essential health services is likely to be immediate, causing delays to diagnosis and treatment for other diseases, including malaria and NTDs. During the Ebola epidemic in West Africa, there were substantial reductions in all-cause outpatient visits and patients treated with antimalarial drugs<sup><xref rid="b2" ref-type="bibr">2</xref></sup>; modeling the potential for similar disruptions in malaria control due to COVID-19 suggests that there could be up to an estimated 769,000 deaths due to malaria in 2020 (approximately double the number seen in 2018), mostly among children younger than 5 years.<sup><xref rid="b3" ref-type="bibr">3</xref></sup> Countries working toward the elimination of malaria or NTDs may face setbacks. Less obvious, but potentially important, is the possibility of SARS-CoV-2 interacting with parasitic infections and changing the rate of severe outcomes, particularly among younger populations that have been relatively less affected by COVID-19 to date.<sup><xref rid="b4" ref-type="bibr">4</xref></sup></p><table-wrap id="t1" position="float"><label>Table 1</label><caption><p>Summary of principal characteristics of COVID-19, malaria, and key neglected tropical diseases</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">Characteristic</th><th align="center" rowspan="1" colspan="1">COVID-19</th><th align="center" rowspan="1" colspan="1">Malaria</th><th align="center" rowspan="1" colspan="1">Soil-transmitted helminths</th><th align="center" rowspan="1" colspan="1">Schistosomiasis</th><th align="center" rowspan="1" colspan="1">Chagas</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Infectious agent</td><td rowspan="1" colspan="1">SARS-CoV-2</td><td rowspan="1" colspan="1"><italic>Plasmodium falciparum</italic>, <italic>Plasmodium vivax</italic>, <italic>Plasmodium ovale</italic>, <italic>Plasmodium malariae</italic>, and <italic>Plasmodium knowlesi</italic></td><td rowspan="1" colspan="1"><italic>Ascaris lumbicoides</italic>, <italic>Trichuris trichiura</italic>, and hookworm (<italic>Ancylostoma duodenale</italic> and <italic>Necator americanus</italic>)</td><td rowspan="1" colspan="1"><italic>Schistosoma mansoni</italic>, <italic>S. haematobium</italic>, and <italic>S. japonicum</italic></td><td rowspan="1" colspan="1">Trypanosoma cruzi</td></tr><tr><td rowspan="1" colspan="1">Principal symptoms of clinical disease</td><td rowspan="1" colspan="1">Fever, cough, and shortness of breath<sup><xref rid="b17" ref-type="bibr">17</xref>,<xref rid="b48" ref-type="bibr">48</xref></sup></td><td rowspan="1" colspan="1">Fever</td><td rowspan="1" colspan="1"><italic>Ascaris</italic> and hookworm: transient pneumonitis. Hookworm and <italic>Trichuris</italic>: abdominal pain, nausea, diarrhea, and anemia</td><td rowspan="1" colspan="1">Often asymptomatic; acute infection causes fever, cough, abdominal pain, diarrhea, hepatosplenomegaly, and eosinophilia.</td><td rowspan="1" colspan="1">Fever, edema, malaise, lymphadenopathy, hepatosplenomegaly, and chagoma (skin nodule at the inoculation site)</td></tr><tr><td rowspan="1" colspan="1">Severe clinical disease manifestation</td><td rowspan="1" colspan="1">Acute respiratory distress syndrome<sup><xref rid="b17" ref-type="bibr">17</xref></sup></td><td rowspan="1" colspan="1">Cerebral malaria, severe anemia, and acute respiratory distress syndrome<sup><xref rid="b15" ref-type="bibr">15</xref></sup></td><td rowspan="1" colspan="1"><italic>Ascaris</italic>: acute intestinal obstruction and peritonitis. Hookworm: anemia. <italic>Trichuris</italic>: colitis, anemia, growth restriction, and dysentery<sup><xref rid="b73" ref-type="bibr">73</xref></sup></td><td rowspan="1" colspan="1"><italic>S. mansoni</italic> and <italic>japonicum</italic>: cirrhosis and portal hypertention. <italic>S. hematobium</italic>: hematuria and squamous cell carcinoma of the bladder; rarely, central nervous system lesions<sup><xref rid="b15" ref-type="bibr">15</xref></sup></td><td rowspan="1" colspan="1">Chronic heart disease, dilated cardiomyopathy, megacolon, and megaesophagus</td></tr><tr><td rowspan="1" colspan="1">Mode of transmission</td><td rowspan="1" colspan="1">Person-to-person, primarily by respiratory droplets</td><td rowspan="1" colspan="1">Mosquito vector</td><td rowspan="1" colspan="1"><italic>Ascaris</italic> and <italic>Trichuris</italic>: ingestion of eggs. Hookworm: larvae penetrate the unprotected skin</td><td rowspan="1" colspan="1">Exposure to water containing larval forms of the parasite which penetrate the skin</td><td rowspan="1" colspan="1">Triatomine vector</td></tr><tr><td rowspan="1" colspan="1">Age-group most affected</td><td rowspan="1" colspan="1">Adults</td><td rowspan="1" colspan="1">Children</td><td rowspan="1" colspan="1">Children and pregnant women</td><td rowspan="1" colspan="1">School-aged children for infection and adults for severe disease</td><td rowspan="1" colspan="1">Children for infection and adults for severe disease<sup><xref rid="b59" ref-type="bibr">59</xref></sup></td></tr></tbody></table></table-wrap><p>Under the assumption that public health and social distancing measures are used to mitigate the epidemic, the modeled estimates for SARS-CoV-2 infection incidence rates for LMICs, assuming comorbidity rates for all countries similar to what was seen in Wuhan, China, are projected to be around 600 infections per 1,000 population, similar to the rate anticipated for high-income countries. However, the mortality rate for LMICs (&#x0223c;2 per 1,000) is projected to be about half that of the high-income countries (&#x0223c;4 per 1,000).<sup><xref rid="b5" ref-type="bibr">5</xref></sup> The difference in predicted mortality rates between LMICs and high-income countries is largely due to the younger age structure in LMICs; in 2020, the median age in sub-Saharan Africa is 18.7 years, compared with 38.4 years in China.<sup><xref rid="b6" ref-type="bibr">6</xref></sup></p><p>Syndemics, or synergistic epidemics, occur when two or more concurrent epidemics have a deleterious interaction,<sup><xref rid="b7" ref-type="bibr">7</xref></sup> that is, when coinfections result in a worse overall outcome than for either individual infection. There are many examples of important interactions between malaria and NTDs and other infectious diseases. For example, malaria plays a role in Epstein&#x02013;Barr virus (EBV) infection, leading to Burkitt&#x02019;s lymphoma by contributing to B-cell proliferation and increasing EBV loads<sup><xref rid="b8" ref-type="bibr">8</xref></sup>; HIV-infected individuals experience a greater frequency of severe malaria and increased HIV viral load following infection with <italic>Plasmodium falciparum</italic><sup><xref rid="b9" ref-type="bibr">9</xref></sup>; several parasite&#x02013;HIV coinfections are associated with increased HIV viral load and worsened immunosuppression<sup><xref rid="b10" ref-type="bibr">10</xref></sup>; and schistosome infections are associated with increased transmission of HIV,<sup><xref rid="b11" ref-type="bibr">11</xref></sup> whereas deworming is associated with decreased HIV viral load and improved CD4 counts among HIV-infected individuals.<sup><xref rid="b12" ref-type="bibr">12</xref></sup> Biological interactions between coinfecting pathogens could involve changes in host pathology related to indirect immune effects.<sup><xref rid="b12" ref-type="bibr">12</xref></sup> The interplay of coinfections hinges on several host&#x02013;pathogen factors and host immunodynamics.</p><p>Low- and middle-income countries in Africa suffer the greatest burden of malaria; in 2018, there were more than 200 million cases per year, with an annual incidence of 229 per 1,000 persons.<sup><xref rid="b13" ref-type="bibr">13</xref></sup> Despite substantial progress in reducing malaria mortality over the past two decades, more than 400,000 malaria deaths (&#x0003e; 90% in sub-Saharan Africa) were estimated to have occurred in 2018.<sup><xref rid="b13" ref-type="bibr">13</xref></sup> Outside of Africa, India has the greatest burden of malaria cases, accounting for 3% of the global burden.<sup><xref rid="b13" ref-type="bibr">13</xref></sup> Globally, NTDs affect more than 1 billion people, especially those living in poverty, who often lack access to clean water and adequate sanitation.<sup><xref rid="b14" ref-type="bibr">14</xref></sup> Africa has a disproportionate burden of NTDs and malaria, with a significant geographical overlap.<sup><xref rid="b14" ref-type="bibr">14</xref>,<xref rid="b15" ref-type="bibr">15</xref></sup> With rapid transmission of SARS-CoV-2, many people in LMICs, particularly in Africa, soon will be coinfected with SARS-CoV-2 and <italic>Plasmodium</italic> spp. or one or more NTD pathogens; cases of COVID-19 in the Africa region will soon surpass 100,000.<sup><xref rid="b1" ref-type="bibr">1</xref></sup> Preexisting infection with any of these parasitic infections may lead to changes in susceptibility and/or severity of COVID-19. It is unclear whether immunomodulation caused by malaria and NTDs will be beneficial or harmful when hosts are coinfected with SARS-CoV-2, but even small changes in the risk of severe outcomes due to coinfections could result in substantial changes in the impact and epidemiology of COVID-19 in LMICs.</p><sec><title>SARS-CoV-2 infection.</title><p>Common symptoms of infection with SARS-CoV-2 include fever, cough, shortness of breath, chills, myalgia, headache, sore throat, and new loss of taste or smell<sup><xref rid="b16" ref-type="bibr">16</xref></sup>; the onset of symptoms generally occurs 4&#x02013;5 days after infection, although it can be as late as 14 days,<sup><xref rid="b17" ref-type="bibr">17</xref>&#x02013;<xref rid="b19" ref-type="bibr">19</xref></sup> and not all infected people develop symptoms.<sup><xref rid="b20" ref-type="bibr">20</xref>&#x02013;<xref rid="b22" ref-type="bibr">22</xref></sup> Approximately a week after the development of symptoms, some patients experience an acute worsening, with a pronounced systemic increase of inflammatory mediators and cytokines.<sup><xref rid="b23" ref-type="bibr">23</xref></sup> The severe systemic inflammatory response, referred to as a &#x0201c;cytokine storm,&#x0201d; is characterized by markedly increased levels of interleukins (IL) and tumor necrosis factor (TNF)-alpha, and is associated with the development of acute respiratory distress syndrome (ARDS).<sup><xref rid="b24" ref-type="bibr">24</xref></sup> Among 72,314 cases reported from China, 14% were rated as severe and 5% were critical (respiratory failure, septic shock, and multiple organ dysfunction or failure).<sup><xref rid="b17" ref-type="bibr">17</xref></sup> Case fatality ratios (CFRs) ranged from 2.3% to 7.2%, with higher CFRs among older adults (8.0&#x02013;12.8% among those aged 70&#x02013;79 years and 14.8&#x02013;20.2% among those 80 years and older, versus &#x02264; 0.4% among those younger than 50 years).<sup><xref rid="b17" ref-type="bibr">17</xref>,<xref rid="b25" ref-type="bibr">25</xref></sup> Hypertension, diabetes, cardiovascular disease, preexisting respiratory disease, and obesity were common comorbidities<sup><xref rid="b26" ref-type="bibr">26</xref>,<xref rid="b27" ref-type="bibr">27</xref></sup>; in a meta-analysis of 1,576 patients in China, all but diabetes and obesity were associated with increased risk of severe disease.<sup><xref rid="b27" ref-type="bibr">27</xref></sup></p></sec><sec><title>Potential <italic>Plasmodium</italic> spp.&#x02013;SARS-CoV-2 interactions.</title><p>Of the five parasitic species that cause malaria in humans (<xref rid="t1" ref-type="table">Table 1</xref>), <italic>P. falciparum</italic> accounts for most morbidity and mortality, followed by <italic>Plasmodium vivax</italic>.<sup><xref rid="b13" ref-type="bibr">13</xref>,<xref rid="b15" ref-type="bibr">15</xref></sup> Clinical illness arises from asexual parasite replication within erythrocytes. Infected erythrocytes lyse and release merozoites into the circulation, causing activation of the immune system and leading to the release of pro-inflammatory cytokines including TNF-alpha, interferon-gamma, IL-6, and IL-12.<sup><xref rid="b28" ref-type="bibr">28</xref></sup> This cascade of cytokines leads to symptoms of uncomplicated malaria, including periodic fever, which, if left untreated, can progress to severe disease. Severe disease manifests as severe anemia, respiratory failure, cerebral malaria, acidosis, and renal failure. Children and infants are at greatest risk for severe malaria; 67% of malarial deaths are estimated to occur among African children younger than 5 years.<sup><xref rid="b13" ref-type="bibr">13</xref></sup></p><p>As with COVID-19, cellular immune responses in malaria involving the cytokine cascade must be carefully regulated to achieve a protective response without causing adverse impact on the host. Studies in malaria-endemic regions have found that it is important to have a balance between a host pro-inflammatory, Th1 response (e.g., TNF-alpha, IL-6, IL-12, and interferon-gamma) and anti-inflammatory, Th2 response (IL-4, IL-10, and others)<sup><xref rid="b29" ref-type="bibr">29</xref>,<xref rid="b30" ref-type="bibr">30</xref></sup>; severe manifestations of malaria are often due to excessive pro-inflammatory responses. The same appears to be true in at least some cases of COVID-19,<sup><xref rid="b18" ref-type="bibr">18</xref></sup> suggesting that a coinfection that also leads to excess pro-inflammatory responses might result in more severe manifestations and poor prognosis.</p><p>Malaria-induced immunosuppression has also been observed in many coinfections, significantly inhibiting immune responses to the other infection (e.g., to <italic>Salmonella</italic> spp.).<sup><xref rid="b31" ref-type="bibr">31</xref>,<xref rid="b32" ref-type="bibr">32</xref></sup> However, malaria-induced immunomodulation has been shown to be protective against severe manifestations of some respiratory viruses. In Kenya, hospitalized children diagnosed with influenza and malaria were less likely to experience respiratory distress than those with influenza alone.<sup><xref rid="b33" ref-type="bibr">33</xref></sup> Coinfection with <italic>Plasmodium</italic> spp. could suppress the production of pulmonary cytokines and decrease the recruitment of cellular inflammatory components to the lungs, leading to reduced clinical symptoms and inflammation, as was found during pneumovirus infections in a murine model. However, in the murine model, viral control was also impaired, leading to increased viral dissemination.<sup><xref rid="b34" ref-type="bibr">34</xref></sup> Similar dynamics could occur during <italic>Plasmodium&#x02013;</italic>SARS-CoV-2 coinfection; malaria-induced immunosuppression might lead to milder manifestations of COVID-19 but simultaneously decrease viral control, potentially increasing or sustaining viral loads, which could increase the potential for viral transmission.</p></sec><sec><title>Age-related vulnerability to malaria and COVID-19.</title><p>Susceptibility to malaria in highly endemic areas differs by age: younger children are more vulnerable to malaria infections and at a higher risk for severe malaria.<sup><xref rid="b13" ref-type="bibr">13</xref></sup> For COVID-19, children are less likely to develop severe disease, whereas older populations are disproportionately affected, with a higher risk of severe disease and death.<sup><xref rid="b35" ref-type="bibr">35</xref></sup> This may be due to the fact that children are more likely to produce T-regulatory cytokines (IL-10, IL-23, and IL-6) and have less inflammation (because of their immature immune systems) than older people who mount a more pro-inflammatory cytokine cascade, potentially contributing to pathogenesis.<sup><xref rid="b35" ref-type="bibr">35</xref></sup> How age-related susceptibility to COVID-19 will play out in Africa, where many children are immunologically stimulated by several infections in addition to malaria, is not clear. Importantly, malaria infections in endemic areas frequently result in chronic, afebrile disease in older children and adults.<sup><xref rid="b36" ref-type="bibr">36</xref></sup> It remains unknown whether this underlying infection will alter susceptibility to or severity of COVID-19 in these populations; it is important that surveillance systems be modified to collect data to inform our understanding of this issue.</p></sec><sec><title>Respiratory distress and ARDS.</title><p>Respiratory distress, observed in up to 25% of adults and 40% of children with severe <italic>P. falciparum</italic> malaria, has several causes, including severe anemia, metabolic acidosis, cytoadherence of infected erythrocytes in pulmonary vasculature, and coinfections with pneumonia-causing pathogens.<sup><xref rid="b37" ref-type="bibr">37</xref></sup> The clinical spectrum varies from mild upper respiratory symptoms to acute lung injury and fatal ARDS. Acute respiratory distress syndrome is rare in young children with malaria but occurs in 5&#x02013;25% of adults and 29% of pregnant women with severe <italic>P. falciparum</italic> infections, and less commonly with <italic>P. vivax</italic> malaria.<sup><xref rid="b37" ref-type="bibr">37</xref></sup> In both malaria and COVID-19, ARDS is linked to inflammatory cytokine&#x02013;mediated increased capillary permeability or endothelial damage, which results in major alveolar damage.<sup><xref rid="b38" ref-type="bibr">38</xref>&#x02013;<xref rid="b40" ref-type="bibr">40</xref></sup> Given this situation, <italic>Plasmodium</italic> spp.&#x02013;SARS-CoV-2 coinfections may result in particularly rapid deterioration, with a poor prognosis. As the inflammatory-mediated alveolar damage in malaria-induced ARDS progresses even after treatment and parasite clearance,<sup><xref rid="b37" ref-type="bibr">37</xref></sup> coinfected individuals may be prone to severe COVID-19. Because both malaria and COVID-19 can lead to similar clinical manifestations, including fever and respiratory symptoms, one or the other may be overlooked in a differential diagnosis of respiratory distress, leading to increased fatalities. As SARS-CoV-2 transmission increases in LMICs, particularly in Africa and India, clinicians should keep this in mind. In addition, documenting the frequency, distribution, and outcomes of these coinfections is important.</p></sec><sec><title>Anemia.</title><p>Anemia is highly prevalent in LMICs and results from multiple causes. In cross-sectional household surveys in sub-Saharan Africa, 61%, 33%, and 3% of children younger than 5 years had any anemia, moderate anemia, and severe anemia, respectively.<sup><xref rid="b13" ref-type="bibr">13</xref></sup> More than one-fifth of children with malaria develop SMA, with a CFR of 8.4%.<sup><xref rid="b41" ref-type="bibr">41</xref></sup> Whereas the hematologic sequelae of COVID-19 are still being elucidated, a meta-analysis describing 1,210 COVID-19 patients from four studies found that hemoglobin values were 0.71 g/dL (95% CI: 0.59&#x02013;0.83 g/dL) lower in individuals with severe disease versus milder disease.<sup><xref rid="b42" ref-type="bibr">42</xref></sup> Whether lower hemoglobin is a risk factor or a sequela of severe COVID-19 disease is unknown. However, because of limited reserves, even small perturbations in oxygen-carrying capacity in individuals with preexisting malarial anemia may result in insufficient tissue oxygenation in the midst of COVID-19&#x02013;induced respiratory failure.</p></sec><sec><title>Pro-coagulant state.</title><p>Numerous viral infections, including SARS-CoV-2, induce a pro-coagulant state through the induction of tissue factor expression, endothelial dysfunction, von Willebrand factor elevation, and Toll-like receptor activation.<sup><xref rid="b43" ref-type="bibr">43</xref>,<xref rid="b44" ref-type="bibr">44</xref></sup> Markers of a hypercoagulable state, including increased D-dimer and fibrin degradation product levels, and prolonged prothrombin time are associated with a poor prognosis.<sup><xref rid="b45" ref-type="bibr">45</xref></sup> Clinically, the hypercoagulable state manifests with a high rate of venous thromboembolism and arterial thrombotic complications (including pulmonary embolism and stroke).<sup><xref rid="b46" ref-type="bibr">46</xref>,<xref rid="b47" ref-type="bibr">47</xref></sup> COVID-19 patients are at risk for developing disseminated intravascular coagulation (DIC),<sup><xref rid="b45" ref-type="bibr">45</xref>,<xref rid="b48" ref-type="bibr">48</xref></sup> and autopsy findings have included both pulmonary hemorrhage and thrombosis.<sup><xref rid="b49" ref-type="bibr">49</xref></sup> Thrombocytopenia is another potential feature of COVID-19, thought to be due to excessive activation of the coagulation cascade, leading to platelet activation and subsequent consumption,<sup><xref rid="b44" ref-type="bibr">44</xref></sup> and is associated with worse outcomes.<sup><xref rid="b50" ref-type="bibr">50</xref></sup></p><p>Malaria is also associated with a pro-coagulant state, with activation of the coagulation cascade, mediated by TNF-alpha and IL-6, proportional to disease severity.<sup><xref rid="b51" ref-type="bibr">51</xref></sup> Whereas micro-thrombotic complications are most commonly described, thrombosis of large vessels, including cerebral venous thrombosis, and pulmonary embolism have been described.<sup><xref rid="b52" ref-type="bibr">52</xref>,<xref rid="b53" ref-type="bibr">53</xref></sup> Thrombocytopenia develops in 60&#x02013;80% of malaria cases.<sup><xref rid="b51" ref-type="bibr">51</xref></sup> Although bleeding and DIC are rarely seen, occurring only in severe malarial cases accompanied by coagulopathy,<sup><xref rid="b54" ref-type="bibr">54</xref></sup> they are associated with high mortality.<sup><xref rid="b51" ref-type="bibr">51</xref></sup> Lysis of activated platelets, along with tissue factor released from damaged vascular endothelial cells, promotes the pro-coagulant state,<sup><xref rid="b54" ref-type="bibr">54</xref></sup> similar to the proposed mechanism in COVID-19. Thus, <italic>Plasmodium</italic> spp.&#x02013;SARS-CoV-2 coinfection could lead to even greater degrees of coagulopathy and more severe disease than with either infection alone.</p></sec><sec><title>Potential interactions between NTDs and COVID-19.</title><p>Helminths, including stool-transmitted helminths (STH), schistosomes, and filariae, typically push the immune system toward anti-inflammatory Th2 pathways through a variety of regulatory mechanisms.<sup><xref rid="b55" ref-type="bibr">55</xref>,<xref rid="b56" ref-type="bibr">56</xref></sup> Protozoal parasites, such as trypanosomes or <italic>Leishmania</italic> spp., are more likely to induce a Th1, pro-inflammatory response. However, there are many deviations from this characterization. Some helminths induce Th1 responses in some stages of the life cycle (e.g., microfilariae of filarial parasites or schistosome eggs), resulting in symptomatic disease, but Th2 responses in other stages (e.g., adults of both filarial parasites and schistosomes). The downregulation of the inflammatory response associated with helminths may reduce the development of immunity or response to vaccines, decrease inflammation associated with autoimmune diseases, reduce the ability to control <italic>Mycobacterium tuberculosis</italic> and <italic>Mycobacterium leprae</italic> coinfections, and reduce the severity of malarial coinfection. The pro-inflammatory effects of some protozoal infections may worsen the severity of some, but not all, viral infections.<sup><xref rid="b55" ref-type="bibr">55</xref>,<xref rid="b57" ref-type="bibr">57</xref></sup> In addition, polyparasitism is quite common, and the overall impact on inflammation depends on the sequence of infections and burden of each.<sup><xref rid="b58" ref-type="bibr">58</xref></sup> Thus, coinfection with parasitic NTDs could result in altered risks and severity of clinical manifestations of SARS-CoV-2 infection, with the potential for decreased development of immunity with increased viral loads.</p><p>The severity of COVID-19 has been associated with underlying health conditions that usually occur with advancing age. Several NTDs, if left untreated, can result in chronic sequelae in much younger populations. For example, because acute <italic>Trypanosoma cruzi</italic> infection is typically asymptomatic or results in a mild, self-limited illness, it is frequently undetected and left untreated. Yet, in young or middle adulthood, 20&#x02013;30% of persons chronically infected with <italic>T. cruzi</italic> develop cardiac manifestations, commonly a complex, dilated cardiomyopathy.<sup><xref rid="b59" ref-type="bibr">59</xref></sup> For these individuals, coinfection with SARS-CoV-2 could be life-threatening. STH infections may result in anemia<sup><xref rid="b60" ref-type="bibr">60</xref></sup>; if, as described previously, anemia predisposes individuals to more severe outcomes, then coinfection of STHs and SARS-CoV-2 in children and pregnant women could be problematic.</p></sec><sec><title>Malnutrition and COVID-19.</title><p>Chronic malnutrition is associated with both malaria<sup><xref rid="b61" ref-type="bibr">61</xref></sup> and NTDs,<sup><xref rid="b62" ref-type="bibr">62</xref></sup> and is relatively common among children in sub-Saharan Africa as well as parts of Latin America and Asia. Prealbumin, a marker for protein malnutrition,<sup><xref rid="b63" ref-type="bibr">63</xref></sup> was found to be lower on admission in patients with COVID-19 who developed ARDS than on those who did not.<sup><xref rid="b64" ref-type="bibr">64</xref></sup> Although lower prealbumin may be a marker for more severe disease, immunosuppression associated with undernutrition preceding infection with SARS-CoV-2 could exacerbate the severity of COVID-19.<sup><xref rid="b65" ref-type="bibr">65</xref>,<xref rid="b66" ref-type="bibr">66</xref></sup> Undernutrition is thought to have led to excess mortality with both the 1918 and H1N1 influenza pandemics.<sup><xref rid="b67" ref-type="bibr">67</xref>,<xref rid="b68" ref-type="bibr">68</xref></sup> Given relatively high rates of undernutrition among children in LMICs (12.3%),<sup><xref rid="b69" ref-type="bibr">69</xref></sup> an association between undernutrition and clinical severity of COVID-19 could increase the proportion of severe illness above current predictions, particularly among children.</p></sec></sec><sec sec-type="conclusion" id="s2"><title>CONCLUSION</title><p>Although SARS-CoV-2 has spread globally, our understanding of the epidemiology and clinical course of COVID-19 in countries with substantial burdens of malaria and NTDs is just beginning, in part because community transmission generally started later in these countries and because testing for SARS-CoV-2 is limited in most LMICs. Although current predictive models suggest lower mortality rates in LMICs than in high-income countries, if coinfections with malaria or parasitic NTDs increase complications with SARS-CoV-2 infections and there is a shift in the age pattern of comorbidities to younger ages, then the burden of COVID-19 in LMICs may be substantially worse than predicted, and potentially higher than the burden in high-income countries.<sup><xref rid="b70" ref-type="bibr">70</xref></sup> If a shift to a Th2 response is more common, and if that shift provides some protection from severe disease while reducing long-term immunity or increasing the time frame of viral shedding, the epidemiology of COVID-19 in LMICs could be substantially different from what has been seen elsewhere.</p><p>Rapidly developing surveillance platforms to monitor signals of SARS-CoV-2 coinfection with malaria or other NTDs will be critical. One early indication of a potential interaction would be a shift in the age pattern of severe COVID-19, with higher rates of clinical disease in children than has been observed in China, Europe, or North America. However, more definitive information on coinfections and outcomes will be needed to interpret such shifts. Efforts to characterize COVID-19 cases in LMICs, such as the WHO First Few X cases protocol,<sup><xref rid="b71" ref-type="bibr">71</xref></sup> and addition of SARS-CoV-2 testing to influenza sentinel surveillance<sup><xref rid="b72" ref-type="bibr">72</xref></sup> could be expanded, based on local prevalence of malaria and NTDs, to include testing for malaria and NTDs. Such additional testing could help determine rates of coinfection and compare severity of outcomes by infection status. Additional efforts to more carefully describe the clinical impacts of coinfections can follow. These efforts are important to understanding the potential impact of COVID-19 on LMICs and for mitigating against the worst outcomes.</p></sec></body><back><ack><title>Acknowledgment:</title><p>Publication charges for this article were waived due to the ongoing pandemic of COVID-19.</p></ack><ref-list><title>REFERENCES</title><ref id="b1"><label>1.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>, <year>2020</year>
<source>WHO Coronavirus Situation Report- 130</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</ext-link>. Accessed May 29, 2020</comment>.</mixed-citation></ref><ref id="b2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plucinski</surname><given-names>MM</given-names></name><etal/></person-group>
<year>2015</year>
<article-title>Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities</article-title>. <source>Lancet Infect Dis</source>
<volume>15</volume>: <fpage>1017</fpage>&#x02013;<lpage>1023</lpage>.<pub-id pub-id-type="pmid">26116183</pub-id></mixed-citation></ref><ref id="b3"><label>3.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group>, <year>2020</year>
<source>The Potential Impact of Health Service Disruptions on the Burden of Malaria: A Modelling Analysis for Countries in Sub-Saharan Africa</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications-detail/the-potential-impact-of-health-service-disruptions-on-the-burden-of-malaria">https://www.who.int/publications-detail/the-potential-impact-of-health-service-disruptions-on-the-burden-of-malaria</ext-link>. Accessed May 21 2020</comment>.</mixed-citation></ref><ref id="b4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludvigsson</surname><given-names>JF</given-names></name></person-group>, <year>2020</year>
<article-title>Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults</article-title>. <source>Acta Paediatr</source>
<volume>109</volume>: <fpage>1088</fpage>&#x02013;<lpage>1095</lpage>.<pub-id pub-id-type="pmid">32202343</pub-id></mixed-citation></ref><ref id="b5"><label>5.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>PGT</given-names></name><etal/></person-group>
<year>2020</year>
<source>Report 12: The Global Impact of COVID-19 and Strategies for Mitigation and Suppression</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-03-26-COVID19-Report-12.pdf">https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-03-26-COVID19-Report-12.pdf</ext-link>. Accessed May 21, 2020</comment>.</mixed-citation></ref><ref id="b6"><label>6.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>United Nations Department of Economic and Social Affairs Population Division</collab></person-group>, <year>2019</year>
<source>World Population Prospects 2019, Custom Data Acquired via Website</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://population.un.org/wpp/DataQuery/">https://population.un.org/wpp/DataQuery/</ext-link>. Accessed April 20, 2020</comment>.</mixed-citation></ref><ref id="b7"><label>7.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>M</given-names></name></person-group>, <year>2009</year>
<source>Introduction to Syndemics: A Critical Systems Approach to Public and Community Health</source>. <publisher-loc>San Francisco, CA</publisher-loc>: <publisher-name>John Wiley &#x00026; Sons</publisher-name>.</mixed-citation></ref><ref id="b8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulama</surname><given-names>DH</given-names></name><name><surname>Bailey</surname><given-names>JA</given-names></name><name><surname>Foley</surname><given-names>J</given-names></name><name><surname>Chelimo</surname><given-names>K</given-names></name><name><surname>Ouma</surname><given-names>C</given-names></name><name><surname>Jura</surname><given-names>WGZO</given-names></name><name><surname>Otieno</surname><given-names>J</given-names></name><name><surname>Vulule</surname><given-names>J</given-names></name><name><surname>Moormann</surname><given-names>AM</given-names></name></person-group>, <year>2014</year>
<article-title>Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer</article-title>. <source>Int J Cancer</source>
<volume>134</volume>: <fpage>645</fpage>&#x02013;<lpage>653</lpage>.<pub-id pub-id-type="pmid">23832374</pub-id></mixed-citation></ref><ref id="b9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwenti</surname><given-names>TE</given-names></name></person-group>, <year>2018</year>
<article-title>Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies</article-title>. <source>Res Rep Trop Med</source>
<volume>9</volume>: <fpage>123</fpage>&#x02013;<lpage>136</lpage>.<pub-id pub-id-type="pmid">30100779</pub-id></mixed-citation></ref><ref id="b10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>GG</given-names></name></person-group>, <year>2016</year>
<article-title>Impacts of neglected tropical disease on incidence and progression of HIV/AIDS, tuberculosis, and malaria: scientific links</article-title>. <source>Int J Infect Dis</source>
<volume>42</volume>: <fpage>54</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">26594012</pub-id></mixed-citation></ref><ref id="b11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>KM</given-names></name><etal/></person-group>
<year>2018</year>
<article-title>Schistosomiasis is associated with incident HIV transmission and death in Zambia</article-title>. <source>PLoS Negl Trop Dis</source>
<volume>12</volume>: <fpage>e0006902</fpage>.<pub-id pub-id-type="pmid">30543654</pub-id></mixed-citation></ref><ref id="b12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faure</surname><given-names>E</given-names></name></person-group>, <year>2014</year>
<article-title>Malarial pathocoenosis: beneficial and deleterious interactions between malaria and other human diseases</article-title>. <source>Front Physiol</source>
<volume>5</volume>: <fpage>441</fpage>.<pub-id pub-id-type="pmid">25484866</pub-id></mixed-citation></ref><ref id="b13"><label>13.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>, <year>2019</year>
<source>World Malaria Report 2019</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>WHO</publisher-name>.</mixed-citation></ref><ref id="b14"><label>14.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>, <year>2020</year>
<source>Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021&#x02013;2030</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>WHO</publisher-name>.</mixed-citation></ref><ref id="b15"><label>15.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>CDC</collab></person-group>, <year>2020</year>
<source>Parasites</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/parasites/">https://www.cdc.gov/parasites/</ext-link></comment>.</mixed-citation></ref><ref id="b16"><label>16.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>CDC</collab></person-group>, <year>2020</year>
<source>Symptoms of Coronavirus</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html">https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html</ext-link>. Accessed May 1, 2020</comment>.</mixed-citation></ref><ref id="b17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>McGoogan</surname><given-names>JM</given-names></name></person-group>, <year>2020</year>
<article-title>Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention</article-title>. <source>JAMA</source>
<volume>323</volume>: <fpage>1239</fpage>&#x02013;<lpage>1242</lpage>.</mixed-citation></ref><ref id="b18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C</given-names></name><etal/></person-group>
<year>2020</year>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>. <source>Lancet</source>
<volume>395</volume>: <fpage>497</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="b19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>S</given-names></name><etal/></person-group>
<year>2020</year>
<article-title>Hospitalizaiton rates and characteristics of patients hospitalized with laboratory-confirmed conronavirus disease 2019 - COVID-NET, 14 states, March 1&#x02013;30, 2020</article-title>. <source>Morb Mortal Wkly Rep</source>
<volume>69</volume>: <fpage>458</fpage>&#x02013;<lpage>464</lpage>.</mixed-citation></ref><ref id="b20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiura</surname><given-names>H</given-names></name><etal/></person-group>
<year>2020</year>
<article-title>Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)</article-title>. <source>Int J Infect Dis</source>
<volume>94</volume>: <fpage>154</fpage>&#x02013;<lpage>155</lpage>.<pub-id pub-id-type="pmid">32179137</pub-id></mixed-citation></ref><ref id="b21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizumoto</surname><given-names>K</given-names></name><name><surname>Kagaya</surname><given-names>K</given-names></name><name><surname>Zarebski</surname><given-names>A</given-names></name><name><surname>Chowell</surname><given-names>G</given-names></name></person-group>, <year>2020</year>
<article-title>Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess Cruise ship, Yokohama, Japan, 2020</article-title>. <source>Euro Surveill</source>
<volume>25</volume>: <fpage>2000180</fpage>.</mixed-citation></ref><ref id="b22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimball</surname><given-names>A</given-names></name><etal/></person-group>
<year>2020</year>
<article-title>Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility&#x02013;King County, Washington, March 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>
<volume>69</volume>: <fpage>377</fpage>&#x02013;<lpage>381</lpage>.<pub-id pub-id-type="pmid">32240128</pub-id></mixed-citation></ref><ref id="b23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name></person-group>, <year>2020</year>
<article-title>The pathogenesis and treatment of the &#x02018;Cytokine Storm&#x02019; in COVID-19</article-title>. <source>J Infect</source>
<volume>80</volume>: <fpage>607</fpage>&#x02013;<lpage>613</lpage>.<pub-id pub-id-type="pmid">32283152</pub-id></mixed-citation></ref><ref id="b24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>YC</given-names></name><name><surname>Liang</surname><given-names>WG</given-names></name><name><surname>Chen</surname><given-names>FW</given-names></name><name><surname>Hsu</surname><given-names>JH</given-names></name><name><surname>Yang</surname><given-names>JJ</given-names></name><name><surname>Chang</surname><given-names>MS</given-names></name></person-group>, <year>2020</year>
<article-title>IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha</article-title>. <source>J Immunol</source>
<volume>169</volume>: <fpage>4288</fpage>&#x02013;<lpage>4297</lpage>.</mixed-citation></ref><ref id="b25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onder</surname><given-names>G</given-names></name><name><surname>Rezza</surname><given-names>G</given-names></name><name><surname>Brusaferro</surname><given-names>S</given-names></name></person-group>, <year>2020</year>
<article-title>Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy</article-title>. <source>JAMA</source>
<pub-id pub-id-type="doi">10.1001/jama.2020.4683</pub-id>.</mixed-citation></ref><ref id="b26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lighter</surname><given-names>J</given-names></name><name><surname>Phillips</surname><given-names>M</given-names></name><name><surname>Hochman</surname><given-names>S</given-names></name><name><surname>Sterling</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Francois</surname><given-names>F</given-names></name><name><surname>Stachel</surname><given-names>A</given-names></name></person-group>, <year>2020</year>
<article-title>Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission</article-title>. <source>Clin Infect Dis</source>
<pub-id pub-id-type="doi">10.1093/cid/ciaa415</pub-id>.</mixed-citation></ref><ref id="b27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Gou</surname><given-names>X</given-names></name><name><surname>Pu</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Ji</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group>, <year>2020</year><article-title>Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis</article-title>. <source>Int J Infect Dis</source>
<volume>94</volume>: <fpage>91</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">32173574</pub-id></mixed-citation></ref><ref id="b28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucsan</surname><given-names>AN</given-names></name><name><surname>Williamson</surname><given-names>KC</given-names></name></person-group>, <year>2020</year>
<article-title>Setting the stage: the initial immune response to blood-stage parasites</article-title>. <source>Virulence</source>
<volume>11</volume>: <fpage>88</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">31900030</pub-id></mixed-citation></ref><ref id="b29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Othoro</surname><given-names>C</given-names></name><name><surname>Lal</surname><given-names>AA</given-names></name><name><surname>Nahlen</surname><given-names>B</given-names></name><name><surname>Koech</surname><given-names>D</given-names></name><name><surname>Orago</surname><given-names>AS</given-names></name><name><surname>Udhayakumar</surname><given-names>V</given-names></name></person-group>, <year>1999</year>
<article-title>A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya</article-title>. <source>J Infect Dis</source>
<volume>179</volume>: <fpage>279</fpage>&#x02013;<lpage>282</lpage>.<pub-id pub-id-type="pmid">9841855</pub-id></mixed-citation></ref><ref id="b30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akanmori</surname><given-names>BD</given-names></name><name><surname>Kurtzhals</surname><given-names>JA</given-names></name><name><surname>Goka</surname><given-names>BQ</given-names></name><name><surname>Adabayeri</surname><given-names>V</given-names></name><name><surname>Ofori</surname><given-names>MF</given-names></name><name><surname>Nkrumah</surname><given-names>FK</given-names></name><name><surname>Behr</surname><given-names>C</given-names></name><name><surname>Hviid</surname><given-names>L</given-names></name></person-group>, <year>2000</year>
<article-title>Distinct patterns of cytokine regulation in discrete clinical forms of <italic>Plasmodium falciparum</italic> malaria</article-title>. <source>Eur Cytokine Netw</source>
<volume>11</volume>: <fpage>113</fpage>&#x02013;<lpage>118</lpage>.<pub-id pub-id-type="pmid">10705308</pub-id></mixed-citation></ref><ref id="b31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lokken</surname><given-names>KL</given-names></name><name><surname>Stull-Lane</surname><given-names>AR</given-names></name><name><surname>Poels</surname><given-names>K</given-names></name><name><surname>Tsolis</surname><given-names>RM</given-names></name></person-group>, <year>2018</year>
<article-title>Malaria parasite-mediated alteration of macrophage function and increased iron availability predispose to disseminated nontyphoidal <italic>Salmonella</italic> infection</article-title>. <source>Infect Immun</source>
<volume>86</volume>: <fpage>e00301</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">29986892</pub-id></mixed-citation></ref><ref id="b32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooney</surname><given-names>JP</given-names></name><etal/></person-group>
<year>2014</year>
<article-title>The mucosal inflammatory response to non-typhoidal <italic>Salmonella</italic> in the intestine is blunted by IL-10 during concurrent malaria parasite infection</article-title>. <source>Mucosal Immunol</source>
<volume>7</volume>: <fpage>1302</fpage>&#x02013;<lpage>1311</lpage>.<pub-id pub-id-type="pmid">24670425</pub-id></mixed-citation></ref><ref id="b33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>MG</given-names></name><etal/></person-group>
<year>2012</year>
<article-title>Influenza and malaria coinfection among young children in western Kenya, 2009&#x02013;2011</article-title>. <source>J Infect Dis</source>
<volume>206</volume>: <fpage>1674</fpage>&#x02013;<lpage>1684</lpage>.<pub-id pub-id-type="pmid">22984118</pub-id></mixed-citation></ref><ref id="b34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>CL</given-names></name><etal/></person-group>
<year>2015</year>
<article-title>Coinfection with blood-stage <italic>Plasmodium</italic> promotes systemic type I interferon production during pneumovirus infection but impairs inflammation and viral control in the lung</article-title>. <source>Clin Vaccine Immunol</source>
<volume>22</volume>: <fpage>477</fpage>&#x02013;<lpage>483</lpage>.<pub-id pub-id-type="pmid">25716232</pub-id></mixed-citation></ref><ref id="b35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saghazadeh</surname><given-names>A</given-names></name><name><surname>Rezaei</surname><given-names>N</given-names></name></person-group>, <year>2020</year>
<article-title>Immune-epidemiological parameters of the novel coronavirus - a perspective</article-title>. <source>Expert Rev Clin Immunol</source>
<pub-id pub-id-type="doi">10.1080/1744666X.2020.1750954</pub-id>.</mixed-citation></ref><ref id="b36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindblade</surname><given-names>KA</given-names></name><name><surname>Steinhardt</surname><given-names>L</given-names></name><name><surname>Samuels</surname><given-names>A</given-names></name><name><surname>Kachur</surname><given-names>SP</given-names></name><name><surname>Slutsker</surname><given-names>L</given-names></name></person-group>, <year>2013</year>
<article-title>The silent threat: asymptomatic parasitemia and malaria transmission</article-title>. <source>Expert Rev Anti Infect Ther</source>
<volume>11</volume>: <fpage>623</fpage>&#x02013;<lpage>639</lpage>.<pub-id pub-id-type="pmid">23750733</pub-id></mixed-citation></ref><ref id="b37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>WRJ</given-names></name><name><surname>Hanson</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>GDH</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name><name><surname>Dondorp</surname><given-names>AM</given-names></name></person-group>, <year>2012</year>
<article-title>Respiratory manifestations of malaria</article-title>. <source>Chest</source>
<volume>142</volume>: <fpage>492</fpage>&#x02013;<lpage>505</lpage>.<pub-id pub-id-type="pmid">22871759</pub-id></mixed-citation></ref><ref id="b38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Ji</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Duan</surname><given-names>G</given-names></name></person-group>, <year>2020</year>
<article-title>Virology, epidemiology, pathogenesis, and control of COVID-19</article-title>. <source>Viruses</source>
<volume>12</volume>: <fpage>372</fpage>.</mixed-citation></ref><ref id="b39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Steen</surname><given-names>PE</given-names></name><name><surname>Deroost</surname><given-names>K</given-names></name><name><surname>Deckers</surname><given-names>J</given-names></name><name><surname>Van Herck</surname><given-names>E</given-names></name><name><surname>Struyf</surname><given-names>S</given-names></name><name><surname>Opdenakker</surname><given-names>G</given-names></name></person-group>, <year>2013</year>
<article-title>Pathogenesis of malaria-associated acute respiratory distress syndrome</article-title>. <source>Trends Parasitol</source>
<volume>29</volume>: <fpage>346</fpage>&#x02013;<lpage>358</lpage>.<pub-id pub-id-type="pmid">23742967</pub-id></mixed-citation></ref><ref id="b40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>P</given-names></name><name><surname>McAuley</surname><given-names>DF</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Sanchez</surname><given-names>E</given-names></name><name><surname>Tattersall</surname><given-names>RS</given-names></name><name><surname>Manson</surname><given-names>JJ</given-names></name></person-group>, <year>2020</year>
<article-title>COVID-19: consider cytokine storm syndromes and immunosuppression</article-title>. <source>Lancet</source>
<volume>395</volume>: <fpage>1033</fpage>&#x02013;<lpage>1034</lpage>.<pub-id pub-id-type="pmid">32192578</pub-id></mixed-citation></ref><ref id="b41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>T</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network</article-title>. <source>Trans R Soc Trop Med Hyg</source>
<volume>100</volume>: <fpage>615</fpage>&#x02013;<lpage>622</lpage>.<pub-id pub-id-type="pmid">16551469</pub-id></mixed-citation></ref><ref id="b42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippi</surname><given-names>G</given-names></name><name><surname>Mattiuzzi</surname><given-names>C</given-names></name></person-group>, <year>2020</year>
<article-title>Hemoglobin value may be decreased in patients with severe coronavirus disease 2019</article-title>. <source>Hematol Transfus Cell Ther</source>
<volume>S2531&#x02013;1379</volume>: <fpage>30029</fpage>&#x02013;<lpage>30028</lpage>.</mixed-citation></ref><ref id="b43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visseren</surname><given-names>F</given-names></name><name><surname>Bouwman</surname><given-names>JJ</given-names></name><name><surname>Bouter</surname><given-names>KP</given-names></name><name><surname>Diepersloot</surname><given-names>RJ</given-names></name><name><surname>de Groot</surname><given-names>PH</given-names></name><name><surname>Erkelens</surname><given-names>DW</given-names></name></person-group>, <year>2000</year>
<article-title>Procoagulant activity of endothelial cells after infection with respiratory viruses</article-title>. <source>Thromb Haemost</source>
<volume>84</volume>: <fpage>319</fpage>&#x02013;<lpage>324</lpage>.<pub-id pub-id-type="pmid">10959707</pub-id></mixed-citation></ref><ref id="b44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannis</surname><given-names>D</given-names></name><name><surname>Ziogas</surname><given-names>IA</given-names></name><name><surname>Gianni</surname><given-names>P</given-names></name></person-group>, <year>2020</year>
<article-title>Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past</article-title>. <source>J Clin Virol</source>
<volume>127</volume>: <fpage>104362</fpage>.<pub-id pub-id-type="pmid">32305883</pub-id></mixed-citation></ref><ref id="b45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name></person-group>, <year>2020</year>
<article-title>Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia</article-title>. <source>J Thromb Haemost</source>
<volume>18</volume>: <fpage>844</fpage>&#x02013;<lpage>847</lpage>.<pub-id pub-id-type="pmid">32073213</pub-id></mixed-citation></ref><ref id="b46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klok</surname><given-names>FA</given-names></name><etal/></person-group>
<year>2020</year>
<article-title>Incidence of thrombotic complications in critically ill ICU patients with COVID-19</article-title>. <source>Thromb Res</source>
<pub-id pub-id-type="doi">10.1016/j.thromres.2020.04.013</pub-id>.</mixed-citation></ref><ref id="b47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oxley</surname><given-names>TJ</given-names></name><etal/></person-group>
<year>2020</year>
<article-title>Large-vessel stroke as a presenting feature of COVID-19 in the young</article-title>. <source>N Engl J Med</source>
<volume>382</volume>: <fpage>e60</fpage>.<pub-id pub-id-type="pmid">32343504</pub-id></mixed-citation></ref><ref id="b48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>W-J</given-names></name><etal/></person-group>
<year>2020</year>
<article-title>Clinical characteristics of coronavirus disease 2019 in China</article-title>. <source>N Engl J Med</source>
<volume>382</volume>: <fpage>1708</fpage>&#x02013;<lpage>1720</lpage>.<pub-id pub-id-type="pmid">32109013</pub-id></mixed-citation></ref><ref id="b49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>SE</given-names></name><name><surname>Akmatbekov</surname><given-names>A</given-names></name><name><surname>Harbert</surname><given-names>JL</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Brown</surname><given-names>JQ</given-names></name><name><surname>Vander Heide</surname><given-names>RS</given-names></name></person-group>, <year>2020</year>
<article-title>Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans</article-title>. <source>Lancet</source>
<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30243-5</pub-id>.</mixed-citation></ref><ref id="b50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippi</surname><given-names>G</given-names></name><name><surname>Plebani</surname><given-names>M</given-names></name><name><surname>Henry</surname><given-names>BM</given-names></name></person-group>, <year>2020</year>
<article-title>Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis</article-title>. <source>Clinica Chim Acta</source>
<volume>506</volume>: <fpage>145</fpage>&#x02013;<lpage>148</lpage>.</mixed-citation></ref><ref id="b51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angchaisuksiri</surname><given-names>P</given-names></name></person-group>, <year>2014</year>
<article-title>Coagulopathy in malaria</article-title>. <source>Thromb Res</source>
<volume>133</volume>: <fpage>5</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">24099998</pub-id></mixed-citation></ref><ref id="b52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>A</given-names></name><name><surname>Karnad</surname><given-names>DR</given-names></name><name><surname>Limaye</surname><given-names>U</given-names></name><name><surname>Siddharth</surname><given-names>W</given-names></name></person-group>, <year>2004</year>
<article-title>Cerebral venous and dural sinus thrombosis in severe falciparum malaria</article-title>. <source>J Infect</source>
<volume>48</volume>: <fpage>86</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">14667796</pub-id></mixed-citation></ref><ref id="b53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musoke</surname><given-names>C</given-names></name><name><surname>Ssendikadiwa</surname><given-names>C</given-names></name><name><surname>Babua</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>JI</given-names></name></person-group>, <year>2014</year>
<article-title>Severe falciparum malaria associated with massive pulmonary embolism</article-title>. <source>Ann Afr Med</source>
<volume>13</volume>: <fpage>47</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">24521579</pub-id></mixed-citation></ref><ref id="b54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srichaikul</surname><given-names>T</given-names></name></person-group>, <year>1993</year>
<article-title>Hemostatic alterations in malaria</article-title>. <source>Southeast Asian J Trop Med Public Health</source>
<volume>24</volume> (<issue>Suppl 1</issue>): <fpage>86</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">7886615</pub-id></mixed-citation></ref><ref id="b55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bashi</surname><given-names>T</given-names></name><name><surname>Bizzaro</surname><given-names>G</given-names></name><name><surname>Ben-Ami Shor</surname><given-names>D</given-names></name><name><surname>Blank</surname><given-names>M</given-names></name><name><surname>Shoenfeld</surname><given-names>Y</given-names></name></person-group>, <year>2015</year>
<article-title>The mechanisms behind helminth&#x02019;s immunomodulation in autoimmunity</article-title>. <source>Autoimmun Rev</source>
<volume>14</volume>: <fpage>98</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">25449677</pub-id></mixed-citation></ref><ref id="b56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maizels</surname><given-names>RM</given-names></name><name><surname>McSorley</surname><given-names>HJ</given-names></name></person-group>, <year>2016</year>
<article-title>Regulation of the host immune system by helminth parasites</article-title>. <source>J Allergy Clin Immunol</source>
<volume>138</volume>: <fpage>666</fpage>&#x02013;<lpage>675</lpage>.<pub-id pub-id-type="pmid">27476889</pub-id></mixed-citation></ref><ref id="b57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>FE</given-names></name></person-group>, <year>2001</year>
<article-title>Concomitant infections, parasites and immune responses</article-title>. <source>Parasitology</source>
<volume>122</volume> (<issue>Suppl</issue>): <fpage>S23</fpage>&#x02013;<lpage>S38</lpage>.<pub-id pub-id-type="pmid">11442193</pub-id></mixed-citation></ref><ref id="b58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supali</surname><given-names>T</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Polyparasitism and its impact on the immune system</article-title>. <source>Int J Parasitol</source>
<volume>40</volume>: <fpage>1171</fpage>&#x02013;<lpage>1176</lpage>.<pub-id pub-id-type="pmid">20580905</pub-id></mixed-citation></ref><ref id="b59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Molina</surname><given-names>JA</given-names></name><name><surname>Molina</surname><given-names>I</given-names></name></person-group>, <year>2018</year>
<article-title>Chagas disease</article-title>. <source>Lancet</source>
<volume>391</volume>: <fpage>82</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">28673423</pub-id></mixed-citation></ref><ref id="b60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>SJ</given-names></name><etal/></person-group>
<year>2016</year>
<article-title>Complexities and perplexities: a critical appraisal of the evidence for soil-transmitted helminth infection-related morbidity</article-title>. <source>PLoS Negl Trop Dis</source>
<volume>10</volume>: <fpage>e0004566</fpage>.<pub-id pub-id-type="pmid">27196100</pub-id></mixed-citation></ref><ref id="b61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>D</given-names></name><etal/></person-group>
<year>2018</year>
<article-title>Complex interactions between malaria and malnutrition: a systematic literature review</article-title>. <source>BMC Med</source>
<volume>16</volume>: <fpage>186</fpage>.<pub-id pub-id-type="pmid">30371344</pub-id></mixed-citation></ref><ref id="b62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tickell</surname><given-names>KD</given-names></name><name><surname>Walson</surname><given-names>JL</given-names></name></person-group>, <year>2016</year>
<article-title>Nutritional enteric failure: neglected tropical diseases and childhood stunting</article-title>. <source>PLoS Negl Trop Dis</source>
<volume>10</volume>: <fpage>e0004523</fpage>.<pub-id pub-id-type="pmid">27124296</pub-id></mixed-citation></ref><ref id="b63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>FK</given-names></name><name><surname>Rosenthal</surname><given-names>TC</given-names></name></person-group>, <year>2002</year>
<article-title>Prealbumin: a marker for nutritional evaluation</article-title>. <source>Am Fam Physician</source>
<volume>65</volume>: <fpage>1575</fpage>&#x02013;<lpage>1578</lpage>.<pub-id pub-id-type="pmid">11989633</pub-id></mixed-citation></ref><ref id="b64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name><etal/></person-group>
<year>2020</year>
<article-title>Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China</article-title>. <source>JAMA Intern Med</source>
<pub-id pub-id-type="doi">10.1001/jamainternmed.2020.0994</pub-id>.</mixed-citation></ref><ref id="b65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourke</surname><given-names>CD</given-names></name><name><surname>Berkley</surname><given-names>JA</given-names></name><name><surname>Prendergast</surname><given-names>AJ</given-names></name></person-group>, <year>2016</year>
<article-title>Immune dysfunction as a cause and consequence of malnutrition</article-title>. <source>Trends Immunol</source>
<volume>37</volume>: <fpage>386</fpage>&#x02013;<lpage>398</lpage>.<pub-id pub-id-type="pmid">27237815</pub-id></mixed-citation></ref><ref id="b66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaible</surname><given-names>UE</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>, <year>2007</year>
<article-title>Malnutrition and infection: complex mechanisms and global impacts</article-title>. <source>PLoS Med</source>
<volume>4</volume>: <fpage>e115</fpage>.<pub-id pub-id-type="pmid">17472433</pub-id></mixed-citation></ref><ref id="b67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>ID</given-names></name></person-group>, <year>1986</year>
<article-title>The 1918&#x02013;1919 influenza pandemic&#x02013;the Indian experience</article-title>. <source>Indian Econ Soc Hist Rev</source>
<volume>23</volume>: <fpage>1</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">11617178</pub-id></mixed-citation></ref><ref id="b68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname><given-names>L</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Population-based surveillance for 2009 pandemic influenza A (H1N1) virus in Guatemala, 2009</article-title>. <source>Influenza Other Respir Viruses</source>
<volume>4</volume>: <fpage>129</fpage>&#x02013;<lpage>140</lpage>.<pub-id pub-id-type="pmid">20409209</pub-id></mixed-citation></ref><ref id="b69"><label>69.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Food and Agriculture Organization of the United Nations</collab></person-group>, <year>2020</year>
<source>Sustainable Development Goals: Indicator 2.1.1 - Prevalence of Undernourishment</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.fao.org/sustainable-development-goals/indicators/211/en/">http://www.fao.org/sustainable-development-goals/indicators/211/en/</ext-link>. Accessed April 21, 2020</comment>.</mixed-citation></ref><ref id="b70"><label>70.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>NG</given-names></name><etal/></person-group>
<year>2020</year>
<source>Age-dependent Effects in the Transmission and Control of COVID-19 Epidemics. Supplementary Information</source>. <publisher-loc>London, United Kingdom</publisher-loc>: <publisher-name>London School of Hygiene and Tropical medicine</publisher-name>.</mixed-citation></ref><ref id="b71"><label>71.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>, <year>2020</year>
<source>The First Few X Cases and Contacts (FFX) Investigation Protocol for Coronavirus Disease 2019 (COVID-19)</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>WHO</publisher-name>.</mixed-citation></ref><ref id="b72"><label>72.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>, <year>2020</year>
<source>Operational Considerations for COVID-19 Surveillance Using GISRS</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>WHO</publisher-name>.</mixed-citation></ref><ref id="b73"><label>73.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>American Academy of Pediatrics</collab></person-group>, <year>2018</year>
<source>Red Book: 2018 Report of the Committee on Infectious Diseases</source>, <edition>31st edition</edition>
<publisher-loc>Itasca, IL</publisher-loc>: <publisher-name>American Academy of Pediatrics</publisher-name>.</mixed-citation></ref></ref-list></back></article>